A single-center experience at a tertiary medical center precision medicine clinic provides insight.
Unique barriers can lead to psychiatric medication adherence rates as low as 26%.
Pharmacists can help patients with diabetes save money.
Studies show a need for coordination between the VA health care system and non-VA health care practices to decrease confusion and duplication of services.
Point-of-care testing can vary in complexity, but is always performed at or near a patient and at the site where care or treatment is provided.
Self-audits help onsite frontline pharmacy leaders and team members to assess compliance before an external surveyor enters their pharmacy to inspect medication use processes.
A diagnosis of Clostridioides difficile infection does not instantly require treatment, but new guidelines include recommendations for treatment when warranted.
Each therapy presents a different but effective treatment option.
Critically ill patients treated with a pharmacist-managed insulin protocol achieved higher rates of glucose control than those treated with conventional methods.
Although the opioid epidemic is a broad societal problem, health systems can play a critical role in the response.
A chief pharmacy officer emphasizes the vital role of pharmacists in enhancing patient care, advocating for recognition, and integration within health care systems.
More cost effectiveness data is crucial in advocating for better insurance coverage in the United States.
Panelists discuss how comprehensive educational resources are essential for empowering patients with TD to better understand their condition, actively participate in their treatment decisions, and achieve optimal outcomes through improved self-management and adherence.
This single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.
Members, as well as health plans, pharmacy benefit managers, plan sponsors, and reinsurers want to know how to fund these expensive treatments to ensure positive outcomes.
Anti-Amyloid Antibody Treatments, Subcutaneous Formulations, and Improved Symptom Relief Are Offering New Hope for Patients
Gianni Scappaticci, PharmD, BCOP, outlines a personalized, evidence-based approach to managing steroid-refractory chronic graft-versus-host disease (cGVHD) in a post–haploidentical transplant patient, highlighting the rationale for using ruxolitinib, belumosudil, or their combination based on disease progression and fibrotic features.
By sharpening our vaccine confidence skills and advocating for expanded immunization scopes of practice, we can help improve convenient vaccine access in the US.
CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice.
The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
Katherine Saunders, MD, weighs in on orforglipron’s potential to expand obesity treatment options, improve adherence with a simple oral regimen, and address barriers to care and access.
SMOs offer a range of services, including site selection, patient recruitment, data management, regulatory compliance, and quality assurance.
Precision oncology represents an evolution in therapeutic practice.
The plan first addresses monoclonal antibodies but could eventually be applied to all compounds seeking FDA approval.
Implementing these standards can be logistically challenging.
Data show these cases pose some of the most significant threats to patients and health systems.
With integrated specialty pharmacies enabling health systems to improve patient outcomes and lower total medical costs, every hospital will need a solution to support the growing number of patients on outpatient specialty medications.
Targeted therapies have greatly improved patient outcomes over the past 20 years.